| | | |  | | | | By STAT Staff Natsumi Chikayasu for STAT The eventual answers to these Covid mysteries will determine our relationship with Covid and and how we'll fight a future pandemic. Read More | | By Matthew Herper Karen Ducey/Getty Images At the same time, the data point to how difficult it could be to determine exactly which Covid shots to give as annual boosters. Read More | | By Andrew Joseph Spencer Platt/Getty Images A burgeoning form of Omicron — called BA.2.12.1 — now accounts for nearly one in five Covid-19 cases in the U.S. Read More | | Sponsor content by Dana-Farber Cancer Institute Immunotherapy combination shows significant benefit for patients with advanced melanoma A combination of two drugs that target different proteins on immune system T cells kept advanced melanoma in check significantly longer than one of the drugs alone in a phase 3 clinical trial. The trial, known as the RELATIVITY-047 study, was co-led by Dana–Farber Cancer Institute investigators. The study compared the effectiveness of the drug nivolumab by itself against a combination of the LAG-3 blocking antibody relatlimab and nivolumab given as a fixed-dose. Learn more. | | By Alyssa Jaffee Adobe It's impossible to say how health care will be affected by the "bubble," if there is one. So companies should keep their eyes on their goals. Read More | | By Haider J. Warraich John Moore/Getty Images A severe back injury gave one doctor insights into the plight of the 50 million Americans who live with chronic pain. Read More | |
No comments